Spectral Medical Inc. (TSE:EDT - Get Free Report)'s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.63 and traded as low as C$0.56. Spectral Medical shares last traded at C$0.58, with a volume of 45,960 shares changing hands.
Spectral Medical Stock Up 3.4 %
The firm has a market capitalization of C$168.75 million, a P/E ratio of -8.57 and a beta of 0.96. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The stock has a 50 day moving average of C$0.62 and a 200-day moving average of C$0.55.
Spectral Medical (TSE:EDT - Get Free Report) last posted its quarterly earnings results on Friday, August 9th. The company reported C($0.02) earnings per share (EPS) for the quarter. The firm had revenue of C$0.47 million for the quarter. Research analysts predict that Spectral Medical Inc. will post -0.05 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other news, Director Paul M. Walker sold 150,000 shares of Spectral Medical stock in a transaction on Friday, September 13th. The stock was sold at an average price of C$0.65, for a total value of C$97,500.00. Company insiders own 18.18% of the company's stock.
About Spectral Medical
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Further Reading
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
